Man Group’s Precigen PGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-75,439
Closed -$292K 2549
2026
Q1
$292K Buy
+75,439
New +$310K ﹤0.01% 2218
2022
Q4
Sell
-194,574
Closed -$412K 2160
2022
Q3
$412K Buy
+194,574
New +$410K ﹤0.01% 1578
2019
Q3
Sell
-18,665
Closed -$143K 1883
2019
Q2
$143K Buy
+18,665
New +$100K ﹤0.01% 1817
2018
Q4
Sell
-13,080
Closed -$225K 2068
2018
Q3
$225K Buy
+13,080
New +$195K ﹤0.01% 2003

Other funds holding PGEN

Man Group's PGEN Position: Q2 2026 in Review

Man Group sold out of Precigen (PGEN) in Q2 2026, closing a stake of 75,439 shares — an estimated $292K sold.

Man Group first reported a position in PGEN in Q3 2018 and held it in 4 quarters. The position peaked at $412K in Q3 2022. 211 funds tracked by Wall St. Rank hold PGEN as of Q2 2026.

  • Man Group reported no remaining Precigen position as of Q2 2026 after selling out during the quarter.
  • Man Group sold 75,439 Precigen shares in Q2 2026, an estimated $292K.
  • Man Group first reported a position in Precigen in Q3 2018 and held it in 4 quarters.
  • Man Group's Precigen position peaked at $412K in Q3 2022.
  • 211 funds tracked by Wall St. Rank held Precigen as of Q2 2026.

Based on Man Group's 13F filing for Q2 2026, filed 14 Aug 2026.